AU2002224253A1 - Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases - Google Patents
Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseasesInfo
- Publication number
- AU2002224253A1 AU2002224253A1 AU2002224253A AU2002224253A AU2002224253A1 AU 2002224253 A1 AU2002224253 A1 AU 2002224253A1 AU 2002224253 A AU2002224253 A AU 2002224253A AU 2002224253 A AU2002224253 A AU 2002224253A AU 2002224253 A1 AU2002224253 A1 AU 2002224253A1
- Authority
- AU
- Australia
- Prior art keywords
- diethylaminoethanol
- inflammatory
- prevention
- derivatives
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RO2001/000022 WO2003043629A1 (en) | 2001-11-22 | 2001-11-22 | Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224253A1 true AU2002224253A1 (en) | 2003-06-10 |
Family
ID=20086243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224253A Abandoned AU2002224253A1 (en) | 2001-11-22 | 2001-11-22 | Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1490046A1 (en) |
AU (1) | AU2002224253A1 (en) |
WO (1) | WO2003043629A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145565A (en) * | 2013-03-15 | 2013-06-12 | 河南工业大学 | Preparation method of diester plasticizer containing tertiary amino |
CN106008238B (en) * | 2016-05-24 | 2018-05-04 | 苏州科技大学 | Double Diethylaminoethanol ester citrate compounds of plant growth regulator phthalic acid and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR8298M (en) * | 1967-07-20 | 1970-11-16 | ||
JPH07107108B2 (en) * | 1986-09-09 | 1995-11-15 | 新日本理化株式会社 | Thermoplastic resin composition |
RO102816B1 (en) * | 1988-12-24 | 1991-12-30 | Institutul De Cercertari Chimico-Farmaceutice | Aminophthalic acid derivatives and production method |
-
2001
- 2001-11-22 AU AU2002224253A patent/AU2002224253A1/en not_active Abandoned
- 2001-11-22 EP EP01274785A patent/EP1490046A1/en not_active Withdrawn
- 2001-11-22 WO PCT/RO2001/000022 patent/WO2003043629A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003043629A1 (en) | 2003-05-30 |
EP1490046A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
WO2003034984A9 (en) | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002246152A1 (en) | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases | |
AU2003216586A1 (en) | Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
AU2002363411A1 (en) | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use | |
AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
AU2003278664A1 (en) | 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders | |
AU2003238242A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
AU2003266965A1 (en) | Use of carboxamides for the treatment of tinnitus | |
AU2002224253A1 (en) | Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases | |
AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
AU2003274885A1 (en) | Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders | |
AU2003264954A1 (en) | Pharmaceutical composition for prevention and treatment of kidney diseases | |
AU2003289889A1 (en) | Methods for the treatment of alzheimers disease and compositions therefore | |
AU2003264397A1 (en) | Preventive and/or therapeutic drugs for inflammatory intestinal diseases | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2003232844A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |